Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20091
20102
20131
20152
20161
20181
20201
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
Eli Lilly and Company2
AstraZeneca1
Clovis Oncology, Inc.1
Elevation Oncology1
Genentech, Inc.1
McGill University1
Merck Sharp & Dohme LLC1
Pharmacyclics LLC.1
Royal Marsden NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma14
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Carcinoma2
Pancreatic Neoplasms2
Rectal Neoplasms2
Adenocarcinoma, Mucinous1
Carcinoma, Adenosquamous1
Carcinoma, Squamous Cell1
Colonic Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.